During organogenesis, the issue of size regulation is as important as shape and differentiation. We propose that the regulation of the dimensions of the epithelium and its appendages (length, width, thickness) are based on regulation of cell numbers in speci®c sites, re¯ecting the input and output of cells in that region. This process is in turn regulated by the¯ow from the domain of proliferating cells to the domain of postmitotic differentiated cells. When the homeobox gene Msx-2 is over-expressed in transgenic mice under the control of the CMV promoter, the epidermis is thickened with hyperproliferation and hyperkeratosis. Hairs are shorter and the matrix region is shrunken. We suggest that Msx-2 may be one of the regulators involved in the control of organ size, and the above phenotypes are the manifestations of an increased cellular¯ow from proliferation domain to differentiation domain in the tissue. Key words: dysplasia/hair follicle/hyper-keratosis/ Msx/organogenesis, skin development. Journal of Investigative Dermatology Symposium Proceedings 4:278± 281, 1999
ORGAN SIZE, CELL NUMBER, AND MOLECULAR REGULATORS
The control of size is central to the formation of an organ. During organogenesis, induction determines the site where the organ forms, morphogenesis determines the shape of the organ, and differentiation makes the ®nal structure. Before the ®nal differentiation takes place, however, the organ will grow to a certain size. Among different but related species, organs can be of similar shapes but different sizes (e.g., mice versus rats, or different kinds of dogs). In the same organism, skin appendages, as one organ, can have a large spectrum of sizes (e.g., tail feathers versus down feathers, and scalp hair versus villus hair). Limb skeletons also come with different lengths and widths. Because the size of cells comprising any given organ are roughly the same, the size of the organ is mainly determined by the number of cells it contains. We can assume that the size of an organ in a particular region re¯ects the input of cells minus the output of cells. The input of cells can come from cell proliferation and cell immigration. The output of cells can come from apoptosis and cell emigration. How the orgaǹ`s enses'' its size and stops growth remains a mystery. The issue of how the size of an organ is regulated has just begun to be appreciated (Raff, 1996) .
In the case of skin and skin appendage development, the major regulatory component appears to be the cell proliferation, and this is what we will focus on. Although there has been great progress in understanding the mechanisms underlying cell proliferation (reviewed in Murray, 1995) , how this is related to organ size has not been explored. We propose that the number of cells in the organ that the precursor cells, in this case transient amplifying (TA) cells (Watt, 1998) , can build up depends on the number of divisions that take place during a certain time period. Because the duration of the cell cycle not including G0 or G1 is relatively constant, the size of the organ becomes a function of the time interval that cells are allowed to divide (Fig 1) .
There are different modes of growth. In deregulated new growth such as in tumors, new cells are added at any time to any place, and the enlargement can occur in all dimensions. In regulated new growth, new cells can either be added to the tip as the growth point, as is the case for limb buds, or to the proximal end as is the case in the hair and feather. During the phase of organ growth, as cells in the proliferation domain divide, some transit to differentiation status, therefore reducing the pool of TA cells. We propose a model in which there are positive and negative regulators that control the cellular¯ow from the proliferation domain to differentiation domain (Fig 1) . A similar orderly progression has been shown in the elongation of long bones using the IHH (Indian hedgehog)±patched±PTHrP±PTHrP receptor pathway (Vortkamp et al, 1996) , and in retina development using the Notch±delta pathway (Henrique et al, 1997) . Here we explore the role of the Msx-2 related pathway.
MSX-2 IS A REGULATOR OF GROWTH CONTROL
The Msx genes are transcriptional factors (Davidson, 1995) that are related to the Drosophila Msh gene family (Walldorf et al, 1989) . In vertebrate development, there are three homologs: Msx-1, -2, and -3. Msx-1 and -2 are found expressed in many sites of epithelial± mesenchymal interactions, including the calvaria, limb bud, tooth bud, feather placode, hair follicles, mammary glands, etc. What is their function in these apparently diverse organs? In a broad sense, Msx-1 and -2 seem to be involved in growth control. For example, in craniofacial development, a Pro 148®His mutation of the human Msx-2 gene was found to correlate with Boston-type craniosynostosis (Jabs et al, 1993) . In this case, the premature closure of the sutures limited the growth of the skull and caused a small cranium cavity. This condition was mimicked in transgenic mice expressing a mutant or normal mouse Msx-2 gene (Liu et al, 1995) . The mechanism is believed to be caused by premature differentiation of osteoblast precursors. In the case of Msx-1, targeted disruption of Msx-1 in mouse mutants show abnormalities in the craniofacial bones and small and missing teeth (Satokata and Maas, 1994) In the limb bud, Msx-1 and -2 are expressed in the apical ectodermal ridge (AER) and the mesenchyme beneath it. Their expression are FGF dependent and are proposed to be important for regulating the function of the progress zone (Muneoka and Sassoon, 1992) . By comparing regions of Msx-2 expression with cellular behavior, Msx-2 positive cells show less proliferation than adjacent progress zone cells, and also are correlated with regions of programmed cell death that sculpture out the shape of the limb bud. Msx-2 was ectopically expressed using the RCAS retroviral vector in the posterior limb bud mesenchyme. The results were restricted outgrowth and formation of the skeletal elements, showing phenotypes of truncated limbs with reduced width (Ferrari et al, 1998) . The authors consider the mechanism to be the imbalance in cell proliferation and programmed cell death caused by abnormally high levels of Msx-2 activity.
At the level of cultured cells, Msx-1, -2 are also involved in growth control. A nonbiased study was conducted to search for genes that can reverse the v-Ki-ras transformed NIH 3T3 cell phenotypes. Interestingly, a carboxy-terminal fragment of Msx-2 was isolated that has this ability. Expression of endogenous Msx-2 is also upregulated in NIH3T3 cells transfected with v-Ki-ras (Takahashi et al, 1996) . In myogenic cells, forced expression of Msx-1, but not Msx-2, blocked myogenic differentiation and caused a transformed phenotype (Song et al, 1992) .
These data suggest that Msx-1 and Msx-2 play a key role in regulating cell proliferation, differentiation, and/or programmed cell death. Although the detailed molecular mechanism remains to be determined, here we study the signi®cance in the regulation of organ size using developing skin and skin appendages. Here we also present a working model to show how the cellular¯ow between the proliferation domain and the differentiation domain can modulate the ®nal size of an organ or a region of an organ (Fig 1) . The¯ow is represented by a hypothetical opening in the barrier located between the proliferation and differentiation domain (black to white graded opening). Different molecular regulators can increase or decrease the¯ow. We propose that Msx-2 is one of the molecules that increase the¯ow.
MSX-2, HAIR LENGTH, AND EPIDERMAL THICKNESS
Skin appendages, including hairs and feathers, are of different lengths in different parts of the body. This is most apparent in the feather. In peacock, the tail feathers can be longer than 1 m and grow at a rate of 8 mm per day, in contrast to the¯ight feather that grows at about 4 mm per day. In the human, the scalp hair can also be longer than 1 m, whereas the villus hairs on the face are only a few millimeters long. What factors may regulate the length of skin appendages? In skin development, proliferation seems to play a much more major role compared with cell migration or apoptosis. With focus on the proliferation/differentiation, starting from a ®xed number of TA cells (p), the length along a particular dimension (D) is dependent on the length of a mature epithelial cell (L) times the number of cell divisions that occur, or the time interval that hair precursor cells stay in the proliferation domain divided by the time required for one cell cycle. There are two stages relevant to this discussion: development and hair cycle. We will ®rst focus on development.
Msx-1 and -2 are found to be expressed in developing skin in the feather placode (Noveen et al, 1995) , mouse hair follicle epithelia (Reginelli et al, 1995) , and human skin epithelia (Stelnicki et al, 1997) . To study the effect of high levels of Msx-2 expression on skin development, we produced transgenic mice with Msx-2 driven by a CMV promoter (Jiang et al, 1999) . Over-expression of Msx-2 in skin in vivo caused epidermal dysplasia, hyperkeratosis, desquamation, and akiness. Transgenic mice also showed abnormal hair growth. Hair follicles were misshapen and reduced in size, particularly in the proximal end. The matrix region was shrunken, and keratinization appeared earlier compared with the control. Beyond the matrix region, in the more distal region, the hair cortex and medulla appeared more normal. Hairs were shorter in the beginning, although they eventually caught up in 2 wk.
How do we explain these results? The hair follicles appeared narrower in width and shorter. The matrix epithelia, or the proliferation domain of hair follicles, were shrunken. Keratinization appeared to start earlier. This suggests that increased Msx-2 activity caused precocious maturation of hair precursor cells; by depleting the pool of transient amplifying cells in the matrix, hairs were shorter in the newborn stage (Fig 2A) . Other redundant pathways may act to compensate and the length of hairs eventually recovered. This is consistent with the ®ndings in calvaria and limb, in which the increase of Msx-2 activity leads to a smaller cranium cavity and truncated limb skeleton.
The skin consists of multiple layers of epithelial cells. Cells proliferate in the basal layer and move up as they differentiate. The cells interact to regulate these morphogenetic processes. In Msx-2 transgenic mice the epidermis was thickened. Proliferating cells remained in the single basal layer, and the suprabasal layer was thickened and hyper-keratotic. The expression of DCC and integrin b1 normally found in the basal keratinocytes was reduced in the basal cell population. Above the basal layer, there was an increased layer of cells expressing both basal and suprabasal keratins, suggesting that the identity of cells between the proliferation and differentiation domains was perturbed. We suspect that the mechanism is an accelerated maturation of basal kerationcytes (Fig 2B) .
With Msx-2 over-expression, why does the epidermis become thicker but hair follicles become smaller? One of the possible explanations is the availability of stem cells. In the hair, stem cells are located within the bulge region (Cotsarelis et al, 1990) , and a small limited number are released to the matrix to become the TA cells in the initiation of each hair cycle. Thus the number of TA cells within the follicle is limiting. Premature transition of proliferating cells to the differentiation domain depletes the TA cell pool and leaves a shrunken matrix and shorter hair (Fig 2A) . In contrast, the basal layer of the epidermis contains both stem cells and transient amplifying cells (Watt, 1998) . Whereas Msx-2 also causes enhanced transit of TA cells into the differentiation domain, these cells can be readily compensated by adjacent stem cells, therefore the increased cellular¯ow leads to thickened and hyperkeratotic epidermis (Fig 2B) .
OTHER RELATED MOLECULAR REGULATORS
What molecules may modulate Msx expression? Msx expression has been shown to be regulated by various molecules, including ®broblast growth factors (FGF), Bmps, TGFb, dorsalin, Dlx, syndecan, tenascin, and inhibitor of differentiation (ID) ( Ganan et al, 1998) . Some of these may be among the physiologic molecular candidates to regulate epidermal thickness and hair length.
Among these, FGF and their receptors appear to play a role in skin appendage formation during embryonic development. In embryonic chicken skin, FGF and FGFR are speci®cally expressed in feather germs (Noji et al, 1993) . FGF induce new feather buds from developing chicken skin (Song et al, 1996; Widelitz et al, 1996) . FGF transcripts are also found in the hair follicles of adult mice (reviewed in Widelitz et al, 1997) . Transgenic mouse skin expressing FGF-7 driven by a K14 promoter suppressed hair follicle formation (Guo et al, 1993) , whereas expression of a dominantnegative FGF-7 in transgenic mice produced a wavy shaft resembling that in the rough mutant mouse (Guo et al, 1996) . Transgenic mice expressing a dominant-negative FGFR driven by the K10 promoter show disrupted and thickened epidermis (Werner et al, 1993) . How these phenotypes may involve the Msx pathway remains to be studied.
We have stated that the duration of the hair cycle can also in¯uence the length of hairs. Because anagen is the time proliferating cells are added to the hair ®lament, prolonging the time of anagen can increase the length of hairs. This seems to be the case for Angora mice (Sundberg et al, 1997) . It was shown that the Angora gene has a mutated FGF-5 and FGF-5 knockout mice showed elongated hair phenotypes (Hebert et al, 1994) . The molecular control of the hair cycle is still under investigation (Stenn et al, 1998) , and how FGF-5 acts with other gene networks (Chuong and Noveen, 1999) to control the duration of anagen is not clear. We do know that Msx-2 is also involved in the hair cycle, but the investigation is still ongoing (Wu et al, unpublished data). Msx has been reported to regulate BMP expression (Chen and Zhao, 1998; Ferrari et al, 1998) or to be regulated by BMP (Zou and Niswander, 1996; Marazzi et al, 1997) in different developmental systems. In tooth formation, BMP4 was shown to be both upstream and downstream of Msx-1 (Chen and Maas, 1998) . Inhibition of the BMP pathway by Noggin could alter the shape of teeth by morphologically transforming incisors to molars (Tucker et al, 1998) . Thus these signaling pathways may act together to modulate the shape and size of epithelial appendage organs.
Msx may also affect the molecular pathway involving the Lymphoid enhancer factor, Lef-1 (Kratochwil et al, 1996) . Lef-1 could be a mediator for Wnt signaling transduced by b-catenin (which then binds Lef-1 and enters the nucleus to change gene expression) and may be downstream to Msx-1 in the tooth induction pathway. Over-expression of Lef-1 causes hairs to grow out from the gum region, a sign of activating the induction of all epithelial appendages (Zhou et al, 1995) . Along this line, a stable form of b-catenin controlled by the K14 promoter was shown to induce de novo hair follicle morphogenesis as well as hair tumors (Gat et al, 1998) .
CONCLUSIONS
In summary, the shape and size of epithelial appendage organs are controlled by the net addition of cell numbers in a temporal and spatial speci®c manner. This is controlled by several cellular processes, including proliferation, immigration, death, emigration, and differentiation. The time that cells spend in the proliferation domain is regulated by many molecular pathways. We think Msx-1 and Msx-2 are among the major regulators in¯uencing the transition to the differentiation domain. Together with other molecules that modulate Msx activities, these gene networks (Chuong and Noveen, 1999) act to translate cellular processes (e.g., cell cycle, cytodifferentiation) into morphogenetic processes (e.g., organ size, shape). Analyzing these developmental pathways, and linking the molecular pathways to morpho-regulation during organogenesis (Edelman, 1992) , is an important future goal.
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